Ovalbumin-specific, MHC class I-restricted, αβ-positive, Tc1 and Tc0 CD8+ T cell clones mediate the in vivo inhibition of rat IgE

Journal of Immunology

Volumn 160, Issue 2, 1998, Pages 580-587

  MacAry, Paul A ^a   Holmes, Beverly J ^a   Kemeny, David M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALUMINUM HYDROXIDE; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL CLONE; CONTROLLED STUDY; FEMALE; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOREGULATION; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ALUM COMPOUNDS; ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; CELLS, CULTURED; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; DRUG COMBINATIONS; EPITOPES; FATTY ACIDS, MONOUNSATURATED; FEMALE; FLUORESCENT DYES; HEMOCYANIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MOLLUSCA; OVALBUMIN; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, INBRED STRAINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; STEM CELLS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRYPSIN;

EID: 0031975213     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Attaya, M., S. Jameson, C. K. Martinez, E. Hermel, C. Aldrich, J. Forman, K. F. Lindahl, M. J. Bevan, and J. J. Monaco. 1992. Ham-2 corrects the class I antigen-processing detect in RMA-S cells. Nature 355:647.
2. Van-Endert, P. M., D. Riganelli, G. Greco, K. Fleischhauer, J. Sidney, A. Sette, and J. F. Bach. 1995. The peptide-hinding motif for the human transporter associated with antigen processing. J. Exp. Med. 182:1883.
3. Streicher, H. Z., I. J. Berkower, M. Busch, F. R. Gurd, and J. A. Berzofsky. 1984. Antigen conformation determines processing requirements for T-cell activation. Proc. Natl. Acad. Sci. USA 81:6831.
4. Elliott, T., A. Willis, V. Cerundolo, and A. Townsend. 1995. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1481.
5. Ishioka, G. Y., S. Colon, C. Miles, H. M. Grey, and R. W. Chesnut. 1989. Induction of class 1 MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo. J. Immunol. 143:1094.
6. Kovacsovics-Bankowski, M., K. Clark, B. Benacerraf, and K. L. Rock. 1993. Efficient major histocompatibility complex class 1 presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 90:4942.
7. Norbury, C. C., L. J. Hewlett, A. R. Prestcott, N. Shastri, and C. Watts. 1996. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow derived macrophage. Immunity 3:783.
8. + T cells. Immunol Rev. 123:209.
9. + T cells following the primary immune response results in a high and persistent IgE response in IgE hyporesponsive rats. Eur. J. Immunol. 27:2657.
10. Chen, W., F. R. Carbone, and J. McCluskey. 1993:. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. J. Immunol. Methods 160:49.
11. Brunner, K. T., J. Mauel, J. C. Cerottini, and B. Chapuis. 1968. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181.
12. Taswell, C. 1981. Limiting dilution analysis tor the determination of immuno-competent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
13. Holt, P. G., and C. McMenamin. 1989. Defense against allergic sensitization in the healthy lung: the role of inhalation tolerance. Clin. Exp. Allergy 19:255.
14. Critchfield, J. M., M. K. Racke, J. C. Zuniga-Pflucker, B. Cannella, C. S. Raine, J. Goverman, and M. J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139.
15. Rock, K. L., L. Rothstein, C. Fleishcracker, and S. Gamble. 1992. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen. J. Immunol. 148:3028.
16. Wood, P. J., S. Socarras, and W. Streilein. 1987. Modification of the cytotoxic T cell repertoire in neonatal tolerance. J. Immunol. 139:3236.
17. Mueller, D. L., and M. K. Jenkins. 1995. Molecular mechanisms underlying functional T-cell unresponsiveness. Curr. Opin. Immunol. 7:375.
18. Racke, M. K., J. M. Critchfield, L. Quigley, B. Cannella, C. S. Raine, H. F. McFarland, and M. J. Lenardo. 1996. Intravenous antigen administration as a therapy for autoimmune demyelinating disease. Ann. Neurol. 39:46.
19. Hammerling, G. J., G. Schonrich, F. Momburg, N. Auphan, M. Malissen, B. Malissen, A. M. Schmitt-Verhulst, and B. Arnold. 1991. Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen. Immunol. Rev. 122: 47.
20. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
21. + T cells. Immunology 78:226.
22. Holt, P. G., J. Oliver, N. Bilyk, C. McMenamin, P. G. McMenamin, G. Kraal, and T. Thepen. 1993. Down-regulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177:397.
23. + T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J. Exp. Med. 178:889.
24. Sedgwick, J. D., and P. G. Holt. 1985. Induction of IgE-secreting cells and IgE isotype-specific suppressor T cells in the respiratory lymph nodes of rats in response to antigen inhalation. Cell. Immunol. 94:182.
25. + T cells in the regulation of IgE. Clin. Exp. Allergy 23:466.
26. + T cells. J. Immunol. 147:421.
27. Brown, M. L., P. E. Fields, and R. J. Kurlander. 1992. Metabolic requirements for macrophage presentation of Listeria monocytogenes to immune CD8 T cells. J. Immunol. 148:555.
28. Staerz, U. D., H. Karasuyama, and A. M. Garner. 1987. Cytotoxic T lymphocytes against a soluble protein. Nature 329:449.
29. Yefenof, E., R. Zehavi-Feferman, and R. Guy. 1990. Control of primary and secondary antibody responses by cytotoxic T lymphocytes specific for a soluble antigen. Eur. J. Immunol. 20:1849.
30. + T cells in a mouse model of allergen-induced sensitization. J. Immunol. 152:351.
31. Miller, A., O. Lider, A. B. Roberts, M. B. Sporn, and H. L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89:421.
32. McMenamin, C, C. Pimm, M. McKersey, and P. G. Holt. 1994. Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 265:1869.
33. + T cells into subpopulations with distinct cytokine profiles. J. Immunol. 155:2928.
34. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271.
35. + T cell. Immunol. Today 15:107.
36. + T cells in human disease: lymphokine patterns in leprosy. Chem. Immunol. 54:44.
37. McMenamin, C., M. McKersey, P. Kuhnlein, T. Hunig, and P. G. Holt. 1995. γδ T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J. Immunol. 154:4390.
38. Miller, A., O. Lider, and H. L. Weiner. 1991. Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174:791.
39. Simpson, E. 1988. Suppression of the immune response by cytotoxic T cells. Nature 336:426.